维普中文期刊产品整合服务
29篇 您的检索式:作者名="Kane TM"
    题名 作者 年代 出处 被引量
1Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder显示文摘Kane TM Carson WH Saha AR 2002J Clin Psychiatry2002,63,9:1
2Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder 显示文摘Kane TM Carson WH Saha AR 2002J Clin Psychiatry2002,63,:1
3Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder显示文摘Kane TM Carson WH Saha AR 2002J Clin Psychiatry2002,63,:1
4Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder显示文摘 Carson WH Saha AR 2002J Clin Psychiatry2002,63,:1
5Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder显示文摘Kane TM Carson WH Saha AR 0,,09:1
6Production of secretory diarrhea by intravenous infusion of vaspactive intestinal polypeptide显示文摘Kane MG O'Dorisio TM Krejs GJ 0,,24:1
7CEP -1347/KT-7515,an inhibitor of SAPK/JNK pathway activation,promotes survival and blocks multiple events associated with A beta -induced cortical neuron apoptosis显示文摘Bozyczko-Coyne D O' Kane TM Wu ZL 2001J Neurochem2001,77,3:1
8Efficacy and safety ofaripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder显示文摘Kane TM Carson WH Saha AR 2002J Clin Psychiatry2002,63,:1
9Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder 显示文摘Kane TM Carson WH Saha AR 2002J clin psychiatry2002,63,9:1
10CEP -1347 /KT-7515,an inhibitor of SAPK/JNK pathway activation,promotes survival and blocks multiple events associated with a beta-induced cortical neuron apoptosis显示文摘Bozyczko-Coyne D O' Kane TM Wu ZL 2001J Neurochem2001,77,3:1
11Efficacy and safety ofaripiprazole and haloperidol versus placebo in patients with schizophrenia andschizoaffective disorder显示文摘Kane TM Carson WH Saha AR 0,,:1
12Efficacy and safety of Aripiprazole and haloperidol versus placebo inpatients with schizophrenic and schizoaffective disorder显示文摘Kane TM Carson WH Saha AR er al 2002J Clin Psychinatry2002,63,:1
13Efficacy and safety ofaripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder显示文摘Kane TM Carson WH Saha AR 2002J Clin Psychiatry2002,63,:1
14Efficacy and safety of Aripiprazole and haloperidol versus placebo inpatients with schizophrenic and sehizoaffective disorder 显示文摘Kane TM Carson WH Saha AR 2002J Clin Psychiatry2002,63,:1
15Efficacy and safety of aripiprazole and haloperidol versus placeb in patients with Schizophrenia and Schizoaffective disorde显示文摘Kane TM Carson WH Arha AR 2002J clin psychiatry2002,63,:1
16Efficacy and safety of avipiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder 显示文摘Kane TM Carson WH Saha AR 2002J Clin Psychiatry2002,63,:1
17Efficary and safety ofaripiprzole and haloperidol Versus placebo in patients with Schizophrenia placebo in patients and Schizoaffective disorder显示文摘Kane TM Carson WH Saha AR 2002J Clin psychiatvy2002,63,:1
18Efficacy and safety ofarip- iprazole and haloperidol versus placebo in patients with schizophre- nia end schizoaffective disorders 显示文摘Kane TM Garson WH Saha AR 2002J Cliu Psychiarty2002,63,:1
19Efficacy and safety ofaripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder显示文摘Kane TM Carson WH Saha AR 2002J Clin Psychiatry2002,63,:1
20Eficacy and safety ofaripiprazole and halopeidol versus placebo in patients with schizophrenia and schizoafective disorder显示文摘Kane TM Carson WH Saha AR 2002J Clin Psychiatry2002,63,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费